TrialHIV medicine2015

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

E Z Soliman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.